IOL Chemicals and Pharmaceuticals has received certificate of suitability from European Directorate for the Quality of Medicines & Health Care (EDQM) for its API product ‘Sitagliptin Phosphate Monohydrate’ on October 27, 2025. Sitagliptin Phosphate Monohydrate is an oral antidiabetic medication used to control high blood sugar levels.
IOL Chemicals and Pharmaceuticals is India's one of the leading generic pharmaceutical companies, and is significant player in the Organic chemicals space.